JAMA Oncology Author Interviews

JAMA Oncology Author Interviews

JAMA Network

Share:
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
...Read More
Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
...Read More
Episodes (82)
Newest to Oldest
Sort Episodes:

Assessment of Residual Ca...

16 Sep 2021 | 34 mins 49 secs

Assessment of Residu...

16 Sep 2021 | 34 mins 49 secs

Hypofractionated Image-Gu...

12 Aug 2021 | 16 mins 52 secs

Hypofractionated Ima...

12 Aug 2021 | 16 mins 52 secs

Neuronal Autoantibodies a...

01 Jul 2021 | 16 mins 31 secs

Neuronal Autoantibod...

01 Jul 2021 | 16 mins 31 secs

Trastuzumab, Pertuzumab, ...

24 Jun 2021 | 13 mins 01 sec

Trastuzumab, Pertuzu...

24 Jun 2021 | 13 mins 01 sec

Efficacy and Safety of St...

13 May 2021 | 19 mins 04 secs

Efficacy and Safety ...

13 May 2021 | 19 mins 04 secs

Association Between KRAS ...

15 Apr 2021 | 15 mins 06 secs

Association Between ...

15 Apr 2021 | 15 mins 06 secs

Chronic Toxic Effects Fol...

25 Mar 2021 | 17 mins 39 secs

Chronic Toxic Effect...

25 Mar 2021 | 17 mins 39 secs

Anti–PD-1 Immunotherapy i...

18 Feb 2021 | 29 mins 39 secs

Anti–PD-1 Immunother...

18 Feb 2021 | 29 mins 39 secs

Virtual Care Across a Ter...

07 Jan 2021 | 23 mins 45 secs

Virtual Care Across ...

07 Jan 2021 | 23 mins 45 secs

Osteonecrosis of the Jaw ...

17 Dec 2020 | 13 mins

Osteonecrosis of the...

17 Dec 2020 | 13 mins

Discontinuation of Tyrosi...

12 Nov 2020 | 15 mins 19 secs

Discontinuation of T...

12 Nov 2020 | 15 mins 19 secs

Association of Measurable...

08 Oct 2020 | 13 mins 59 secs

Association of Measu...

08 Oct 2020 | 13 mins 59 secs

Survival and Adjuvant Che...

17 Sep 2020 | 23 mins 11 secs

Survival and Adjuvan...

17 Sep 2020 | 23 mins 11 secs

Tailoring Intensity of Su...

27 Aug 2020 | 18 mins 55 secs

Tailoring Intensity ...

27 Aug 2020 | 18 mins 55 secs

Presence of ctDNA and CTC...

09 Jul 2020 | 13 mins 29 secs

Presence of ctDNA an...

09 Jul 2020 | 13 mins 29 secs